CHRNA9 anticorps (N-Term)
Aperçu rapide pour CHRNA9 anticorps (N-Term) (ABIN926964)
Antigène
Voir toutes CHRNA9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Chien, Souris, Rat (Rattus), Poulet
-
Purification
- Purified
-
Immunogène
- CHRNA9 antibody was raised in rabbit using the N terminal of CHRNA9 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.0625 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CHRNA9 Blocking Peptide, (ABIN5612869), is also available for use as a blocking control in assays to test for specificity of this CHRNA9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Autre désignation
- CHRNA9
-
Sujet
- CHRNA9 is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor superfamily. CHRNA9 is a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. It is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea. Synonyms: Polyclonal CHRNA9 antibody, Anti-CHRNA9 antibody, cholinergic receptor, nicotinic, alpha 9 antibody.
-
Pathways
- Sensory Perception of Sound
Antigène
-